MicuRx Pharmaceuticals has reached a strategic cooperation agreement with Pengbo Biotech for the joint development of ADC drugs

Zhitong
2025.09.26 05:24

According to MicuRx, recently, MicuRx officially signed the "ADC Drug Joint Development Strategic Cooperation Agreement" with Nanjing Pengbo Biotechnology Co., Ltd. Both parties will fully leverage their respective advantages in the "toxin-linker" platform and the "antibody development platform" to jointly discover, research, and develop several innovative targeted antibody-drug conjugates

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer